Comparison
46 Xx Disorder Of Sex Development C2936403 vs 2 Hydroxyglutarate Aciduria C5139239
Clinical comparison between 46 XX Disorder OF Sex Development and 2 Hydroxyglutarate Aciduria for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development C2936403
A variation in typical female sex development involving chromosomal, gonadal, or anatomical differences. Treatment and support are personalized based on individual medical needs.
2 Hydroxyglutarate Aciduria C5139239
A metabolic disorder causing buildup of 2-hydroxyglutaric acid. It may affect the brain and nervous system. Management includes supportive therapies and monitoring for complications.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development C2936403
0-0
2 Hydroxyglutarate Aciduria C5139239
0-10
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development C2936403
severe
2 Hydroxyglutarate Aciduria C5139239
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development C2936403
Chronic
2 Hydroxyglutarate Aciduria C5139239
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development C2936403
No
2 Hydroxyglutarate Aciduria C5139239
No
Different transmission
Body System
46 Xx Disorder Of Sex Development C2936403
reproductive
2 Hydroxyglutarate Aciduria C5139239
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development C2936403
genetic
2 Hydroxyglutarate Aciduria C5139239
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-C2936403 and 2-hydroxyglutarate-aciduria-C5139239 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development C2936403 | 2 Hydroxyglutarate Aciduria C5139239 | Discriminating power |
|---|---|---|---|
| Primary clinical domain | Differences in chromosomal, gonadal, or genital development | Possible neurologic or developmental effects from metabolite buildup | High |
| Onset pattern | Usually recognized around birth or early evaluation | May present from infancy through childhood | Moderate |
| System involvement | Mainly reproductive and endocrine considerations | Mainly metabolic and nervous-system considerations | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development C2936403 when
Atypical genital or gonadal findings
The supplied profile centers on sex development rather than organic acid accumulation
High
46,XX chromosomal context
Karyotype context supports DSD evaluation, not aciduria by itself
Moderate
Need for individualized reproductive care
Management is personalized to anatomy, gonads, and endocrine needs
Moderate
Choose 2 Hydroxyglutarate Aciduria C5139239 when
Suspected inborn error of metabolism
The condition is defined by 2-hydroxyglutaric acid accumulation
High
Neurologic symptoms with metabolic concern
Brain or nervous-system involvement is described as possible
Moderate
Childhood presentation without sex-development findings
Onset may extend through age 10 and involves a different system
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development C2936403 | 2 Hydroxyglutarate Aciduria C5139239 | Interpretation |
|---|---|---|---|
| Karyotype and DSD evaluation | 46,XX context with gonadal or anatomical assessment | Not the defining test for aciduria | Supports left only within a full clinical evaluation |
| Urine organic acid analysis | No defining 2-hydroxyglutarate abnormality expected | May show elevated 2-hydroxyglutaric acid; cutoff not supplied | An abnormal result needs laboratory and clinician confirmation |
| Neurologic assessment or imaging | Not primarily indicated by the supplied profile | May be used if neurologic involvement is suspected | Findings are supportive, not independently diagnostic |
Prognosis comparison
46 Xx Disorder Of Sex Development C2936403
- Outcome
- Chronic course with highly individualized needs; exact outcome not established
- Factors
- Anatomy, gonadal function, endocrine status, and access to coordinated care
2 Hydroxyglutarate Aciduria C5139239
- Outcome
- Chronic metabolic condition with possible neurologic impact; exact outcome not established
- Factors
- Degree of neurologic involvement, complications, and response to supportive care
Time frame: Long-term; onset data suggest birth for left and infancy to childhood for right
Supplied severity differs, but prognosis cannot be quantified from these data
Complications comparison
| Complication | Presentation |
|---|---|
| Gonadal or reproductive complications | Possible and individualized; exact risk not established here Not a described feature of this metabolic condition Do not infer fertility outcomes from these sparse data |
| Neurologic complications | Not established by the supplied description Brain or nervous-system effects may occur Severity and frequency are not specified |
| Long-term monitoring needs | Endocrine, gonadal, and psychosocial follow-up may be needed Metabolic and neurologic monitoring may be needed Plans should be specialist-directed |
Patient education highlights
- HighDifferent conditions
These diagnoses involve different body systems and should not be treated as interchangeable.
- HighAbnormal tests
A laboratory abnormality or anatomical finding is not automatically a complete diagnosis.
- MediumCare planning
Ask clinicians which specialists, monitoring, and supportive therapies apply to the individual.